Global Pharmaceutical News

Researchers advance blood tests’ ability to detect cancer earlier. The latest news on health and wellness, including the healthcare industry

Pharma industry: Proposed ‘forever chemicals’ ban would stifle innovation, access to drugs

The European Commission and international health agencies are closely monitoring a growing incidence of avian influenza in mammals.

EU chemical and pharmaceutical trade: robust growth. [Quantung Pharma – Quantung.com]

Biden administration to provide free Covid vaccines to uninsured Americans this fall through end of 2024

The health area has never been as focused on data as it is today. From the control of expenses to the detection of fraud and the coordinatio

UnitedHealth stock jumps after earnings top estimates despite rising medical costs

The FDA has placed a clinical hold on Hemogenyx Pharmaceuticals’ investigational HEMO-CAR-T, which is being trialed for the treatment of acu

Amid declining demand for COVID-19 vaccines, embattled biotech Novavax is revising its advanced purchase contract with Canada’s department o

Friday, BrainStorm Cell Therapeutics posted positive Phase III data for its amyotrophic lateral sclerosis candidate NurOwn, showing that the

The therapy becomes an option for moderate-to-severe plaque psoriasis in certain adults

Johnson & Johnson has capitalized on the shaky financial ground at French biotech Nanobiotix by licensing its lead product, NBTXR3, intended

A project involving researchers based in Edinburgh wants to establish effective combinations of existing drugs which, used together, could t

GLORIA trial shows increased survival levels among newly diagnosed brain cancer patients TME Pharma – a company concentrating on the develo

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions

PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis

ELATIVE, a randomised PBC trial involving 161 patients, has successfully met its primary endpoint

Therapy has been developed to reduce the frequency, duration and severity of migraine attacks

Partnership establishes several influenza therapy targets using artificial intelligence

Patients treated with Kesimpta experienced considerable decreases in relapse rates